Bevacizumab continuation versus treatment holidays after first-line chemotherapy with bevacizumab in patients
with metastatic colorectal cancer: a health economic analysis of a randomised phase III trial (SAKK 41/06)
Klazien Matter-Walstra, Matthias Schwenkglenks, Daniel Betticher, Roger von Moos, Daniel Dietrich, Daniela Baertschi, Dieter Koeberle, DOI: http://dx.doi.org/10.1016/j.clcc.2016.03.002
Publication stage: In Press Accepted Manuscript
Published online: March 30 2016
Kommentar schreiben